Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
about
Overutilization of proton-pump inhibitors: what the clinician needs to knowGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsPerils and pitfalls of long-term effects of proton pump inhibitors.Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective.Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implicationsAssociation of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumAssociation between proton pump inhibitor use and anemia: a retrospective cohort study.Gastrins, iron homeostasis and colorectal cancerNANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasGastrin-deficient mice have disturbed hematopoiesis in response to iron deficiencyConcomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia.Circulating gastrin is increased in hemochromatosisResolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Pharmacotherapy of Zollinger-Ellison syndrome.Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis.Interrelationships between circulating gastrin and iron status in mice and humans.Esomeprazole: a proton pump inhibitor.Long-term acid inhibition: benefits and harms.Prescribing proton pump inhibitors: is it time to pause and rethink?A benefit-risk assessment of the use of proton pump inhibitors in the elderly.Diagnostic yield of upper gastrointestinal endoscopy in the evaluation of iron deficiency anemia in older children and adolescents.Prevalence and predictive factors for gastrointestinal pathology in young men evaluated for iron deficiency anemia.The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?Large hiatal hernia in patients with iron deficiency anaemia: a prospective study on prevalence and treatment.Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use.Proton Pump Inhibitors: Are They a Real Threat to the Patient?
P2860
Q24634086-B140E5AD-BD2A-404F-9FB9-1FEE14548537Q28290833-4862E78E-031D-416D-A225-CB8AD22F885FQ33409626-4B589AC9-CE00-4220-84C4-19352CCAC674Q33658410-4AC4C8F2-E8E1-403C-A6BA-CFA8FEB0A302Q33949498-22C4A3CB-4AF3-43D4-A791-E61AEEDD578DQ34140914-54881B6B-41F5-4483-8C0C-48C6A65A4F9FQ34164370-0A5ED38E-E8E9-404A-A282-83C5CE5A929CQ34810044-17396E0F-C50F-47DD-B2CB-21118AC44CC7Q35001777-D025CB7F-FC69-451E-BA35-8805EF771EC5Q35110839-F6458915-AC2E-4558-9BC4-DE12B547624BQ35595511-1012D7FC-A539-4710-9DAD-05768B4052C7Q35606936-792A8EFF-D479-40C5-8E04-F2ECDE83EDCDQ35922060-DBDF3FAA-2B16-4D0B-90EB-84427A3CCE7BQ36376528-97C211ED-961D-4EA0-B574-20B62E0961D7Q36632665-3A8B370D-8DEF-44EA-B92B-1B1A99CACABCQ36753973-C53BFA2A-212F-4164-BC78-FC79E1C978EBQ36956094-5BB97F02-2AF7-4688-810D-4B9EEF235551Q37390644-A5B30785-6603-400E-BE18-8EDE1ADC7047Q37957704-192F57AC-4D39-4AA4-B6D8-C41D6558F0C6Q37987204-CB4A2ECD-299D-4CCA-9156-84D434BA90DDQ38196383-DEC2E097-0F91-4D70-AE09-73F7A3914B42Q44117323-AC28B2D5-9512-4D19-93A7-CE3002CF1027Q45104550-7A8688C1-C9E0-4417-BAF8-06655D49154AQ47822235-62288D6D-F384-468F-8B88-7A4F094CE623Q47947378-4D5017C5-8EC6-4299-B284-DC171F8729B5Q49901364-13E1A22B-78B7-40F7-B6EB-39D6328B9AE5Q51761248-60F69CD5-2533-4B1A-8B97-C4CCE1F1E8A4Q55493690-698428E7-5782-471F-90A3-2863EED20BF3Q57494425-33A8E761-88E9-48E5-8210-4126CA5988A3
P2860
Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@en
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@nl
type
label
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@en
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@nl
prefLabel
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@en
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@nl
P2093
P2860
P1476
Iron absorption in patients wi ...... ic acid antisecretory therapy.
@en
P2093
Stewart CA
Sutliff VE
Termanini B
P2860
P356
10.1046/J.1365-2036.1998.00274.X
P407
P577
1998-01-01T00:00:00Z